HomeInsightsPE

Bliss Gvs Pharma Ltd PE Ratio

Bliss Gvs Pharma Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

22.9 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

PE

19.5

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Bliss GVS Pharma Ltd is 19.5 as of 11 Dec 15:30 PM .
  • The P/E Ratio of Bliss GVS Pharma Ltd changed from 15 on March 2019 to 15.6 on March 2024 . This represents a CAGR of 0.66% over 6 years.
  • The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 151.8 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Bliss GVS Pharma Ltd

No data available

Company Fundamentals for Bliss GVS Pharma Ltd

No data available

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

Share Price

₹ 151.8

-3.70 (-2.38%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Dec 2024155.5
09 Dec 2024155.45
06 Dec 2024157.9
05 Dec 2024160.8
04 Dec 2024160.8
03 Dec 2024163.6
02 Dec 2024168.1
29 Nov 2024161.7
28 Nov 2024159.9
27 Nov 2024143.1

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Bliss GVS Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Bliss GVS Pharma Ltd191,637
Sun Pharmaceuticals Industries Ltd384,34,148
Divis Laboratories Ltd851,57,464
Cipla Ltd251,17,560
Torrent Pharmaceuticals Ltd651,13,318
Mankind Pharma Ltd501,06,927

Key Valuation Metric of Bliss GVS Pharma Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Bliss GVS Pharma Ltd

No data available

* All values are in %

About Bliss GVS Pharma Ltd

  • Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
  • The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries' fastest-growing businesses.
  • The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries.
  • It has a strong foothold in Sub Saharan Africa.
  • The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

2024-10-18 00:00:00

News

Bliss GVS Pharma consolidated net profit declines 42.66% in the September 2024 quarter

Net profit of Bliss GVS Pharma declined 42.66% to Rs 24.26 crore in the quarter ended Sept...

Read more

2024-10-25 00:00:00

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

2024-10-04 00:00:00

News

Bliss GVS Pharma soars after manufacturing units get GMP certificate from Romania medical authority

In a regulatory filing made on Saturday, the company informed that its manufacturing facil...

Read more

2024-11-25 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Bliss GVS Pharma Ltd

What is the current PE Ratio of Bliss GVS Pharma Ltd?

The Current PE Ratio of Bliss GVS Pharma Ltd is 19.46 as on 11 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Dec 2024.

What was the PE Ratio of Bliss GVS Pharma Ltd last year?

The PE Ratio of Bliss GVS Pharma Ltd was 10.48 last year, now the PE ratio is 19.46, showing a year-on-year growth of 85.7%.

What does the PE Ratio of Bliss GVS Pharma Ltd indicate about its stock?

The PE Ratio of Bliss GVS Pharma Ltd is 19.46. This ratio indicates that investors are willing to pay 19.46 times the earnings per share for each share of Bliss GVS Pharma Ltd.

What is the PE Ratio Growth of Bliss GVS Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Bliss GVS Pharma Ltd grew by 85.7% whereas, the EPS ratio grew by 17.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions